Annual SGA
$47.30 M
+$29.90 M+171.79%
December 31, 2023
Summary
- As of February 8, 2025, VRCA annual SGA is $47.30 million, with the most recent change of +$29.90 million (+171.79%) on December 31, 2023.
- During the last 3 years, VRCA annual SGA has risen by +$22.80 million (+93.02%).
- VRCA annual SGA is now at all-time high.
Performance
VRCA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$16.08 M
-$439.00 K-2.66%
September 30, 2024
Summary
- As of February 8, 2025, VRCA quarterly SGA is $16.08 million, with the most recent change of -$439.00 thousand (-2.66%) on September 30, 2024.
- Over the past year, VRCA quarterly SGA has dropped by -$3.97 million (-19.80%).
- VRCA quarterly SGA is now -19.80% below its all-time high of $20.05 million, reached on September 30, 2023.
Performance
VRCA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.04 B
-$84.99 M-8.90%
September 30, 2024
Summary
- As of February 8, 2025, VRCA TTM SGA is -$1.04 billion, with the most recent change of -$84.99 million (-8.90%) on September 30, 2024.
- Over the past year, VRCA TTM SGA has dropped by -$1.07 billion (-3204.62%).
- VRCA TTM SGA is now -8263.63% below its all-time high of -$12.44 million.
Performance
VRCA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
VRCA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +171.8% | -19.8% | -3204.6% |
| 3 y3 years | +93.0% | +404.3% | -6075.4% |
| 5 y5 years | +422.6% | +404.3% | -6075.4% |
VRCA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +171.8% | -19.8% | +404.3% | -112.3% | at low |
| 5 y | 5-year | at high | +223.0% | -19.8% | +404.3% | -413.1% | at low |
| alltime | all time | at high | >+9999.0% | -19.8% | >+9999.0% | -8263.6% | at low |
Verrica Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $16.08 M(-2.7%) | $65.94 M(-5.7%) |
| Jun 2024 | - | $16.52 M(+1.1%) | $69.91 M(+17.8%) |
| Mar 2024 | - | $16.34 M(-3.9%) | $59.33 M(+25.4%) |
| Dec 2023 | $47.30 M(+171.8%) | $17.00 M(-15.3%) | $47.30 M(+41.2%) |
| Sep 2023 | - | $20.05 M(+237.8%) | $33.50 M(+92.9%) |
| Jun 2023 | - | $5.94 M(+37.5%) | $17.37 M(+4.6%) |
| Mar 2023 | - | $4.32 M(+35.4%) | $16.61 M(-4.6%) |
| Dec 2022 | $17.41 M(-35.5%) | $3.19 M(-18.8%) | $17.41 M(-10.0%) |
| Sep 2022 | - | $3.92 M(-24.1%) | $19.33 M(-17.4%) |
| Jun 2022 | - | $5.17 M(+1.1%) | $23.41 M(-8.3%) |
| Mar 2022 | - | $5.12 M(+0.1%) | $25.52 M(-5.4%) |
| Dec 2021 | $26.98 M(+10.1%) | $5.11 M(-36.1%) | $26.98 M(-14.7%) |
| Sep 2021 | - | $8.01 M(+9.9%) | $31.63 M(+11.9%) |
| Jun 2021 | - | $7.28 M(+10.7%) | $28.27 M(+8.3%) |
| Mar 2021 | - | $6.58 M(-32.6%) | $26.10 M(+6.5%) |
| Dec 2020 | $24.51 M | $9.76 M(+110.0%) | $24.51 M(+30.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $4.65 M(-9.0%) | $18.77 M(+6.6%) |
| Jun 2020 | - | $5.11 M(+2.4%) | $17.61 M(+9.4%) |
| Mar 2020 | - | $4.99 M(+24.1%) | $16.09 M(+9.9%) |
| Dec 2019 | $14.64 M(+61.8%) | $4.02 M(+15.0%) | $14.64 M(+5.4%) |
| Sep 2019 | - | $3.49 M(-2.8%) | $13.90 M(+4.7%) |
| Jun 2019 | - | $3.59 M(+1.5%) | $13.27 M(+14.1%) |
| Mar 2019 | - | $3.54 M(+8.2%) | $11.63 M(+28.5%) |
| Dec 2018 | $9.05 M(+1145.1%) | $3.27 M(+14.2%) | $9.05 M(+48.5%) |
| Sep 2018 | - | $2.87 M(+46.5%) | $6.10 M(+75.7%) |
| Jun 2018 | - | $1.96 M(+103.4%) | $3.47 M(+112.5%) |
| Mar 2018 | - | $961.00 K(+204.1%) | $1.63 M(+124.6%) |
| Dec 2017 | $727.00 K(+256.4%) | $316.00 K(+32.8%) | $727.00 K(+76.9%) |
| Sep 2017 | - | $238.00 K(+101.7%) | $411.00 K(+137.6%) |
| Jun 2017 | - | $118.00 K(+114.5%) | $173.00 K(+214.5%) |
| Mar 2017 | - | $55.00 K | $55.00 K |
| Dec 2016 | $204.00 K | - | - |
FAQ
- What is Verrica Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals annual SGA year-on-year change?
- What is Verrica Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals quarterly SGA year-on-year change?
- What is Verrica Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals TTM SGA year-on-year change?
What is Verrica Pharmaceuticals annual SGA?
The current annual SGA of VRCA is $47.30 M
What is the all time high annual SGA for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high annual SGA is $47.30 M
What is Verrica Pharmaceuticals annual SGA year-on-year change?
Over the past year, VRCA annual SGA has changed by +$29.90 M (+171.79%)
What is Verrica Pharmaceuticals quarterly SGA?
The current quarterly SGA of VRCA is $16.08 M
What is the all time high quarterly SGA for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high quarterly SGA is $20.05 M
What is Verrica Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, VRCA quarterly SGA has changed by -$3.97 M (-19.80%)
What is Verrica Pharmaceuticals TTM SGA?
The current TTM SGA of VRCA is -$1.04 B
What is the all time high TTM SGA for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high TTM SGA is -$12.44 M
What is Verrica Pharmaceuticals TTM SGA year-on-year change?
Over the past year, VRCA TTM SGA has changed by -$1.07 B (-3204.62%)